WHO Recommends Regeneron Antibody Cocktail For High-Risk Covid Patients

Regeneron’s antibody therapy to treat high-risk Covid-19 patients, the agency announced Friday, adding its voice to calls for the company to lower its prices and ensure equal access to the lifesaving treatment around the world.Key Facts

An expert WHO panel recommended Regeneron’s antibody cocktail for patients at risk of developing severe Covid-19 and patients with severe or critical Covid-19 who haven’t mounted their own antibody response. The group said new studies showed the therapy is most effective in these two groups and was unlikely to significantly benefit others, as it recommended rapid antibody testing to determine the most suitable patients.

Regeneron's high cost—along with the challenges of testing for antibodies—means it could be difficult for lower income countries to access it, the WHO panel said, but added that its backing of the treatment should help boost global access.on Regeneron to “address the high price and limited production” of the treatment, calling on the company to share its technological know-how and allow others to make it.

Regeneron is collaborating with Swiss pharma Roche to increase its global supply and increase access outside the U.S., the companya withering rebuke on the uneven access to Regeneron’s treatment after the WHO’s announcement. “It is simply not fair that people living in low- and middle-income countries cannot access new Covid-19 treatments... because of pharmaceutical companies’ monopolies and wishes for high returns,” said Dr.

who indeed

Wasn’t there this dude who said that he got treated with Regeneron and then was lambasted by the media for it?

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

CDC advisers sign off on Pfizer booster shot for certain groupsA CDC committee voted to recommend booster shots for people ages 65 and up, as well as certain individuals at high-risk for Covid-19. RIP The advisers voted that all people ages 65 and up and those in long-term care facilities who were initially vaccinated with Pfizer should receive a booster dose. People ages 50 to 64 with underlying medical conditions should also get a booster dose.
Source: NBCNews - 🏆 10. / 86 Read more »

WHO backs Regeneron treatment for high-risk patients – latest updatesWHO backs antibody treatment for high-risk Covid patients. Here are other Covid19 updates: 🇧🇷 Brazil approaches 600,000 virus deaths 🇰🇷 South Korea reports record high daily cases of 2,434 🇦🇺 Melbourne cases linger near record levels For more: Russia sees record 828 Covid deaths in 24 hours. Other updates: 🇪🇬 Egypt okays one-dose Sputnik Light for use 🇻🇳 Vietnam delays reopening resort island over low vaccinations 💉 Study: Sinovac shot highly effective against serious illness For more:
Source: trtworld - 🏆 101. / 63 Read more »

CDC panel recommends Pfizer booster shots for seniors, declines them for healthcare workersGovernment advisors on Thursday recommended booster doses of Pfizer’s COVID-19 vaccine for millions of Americans.
Source: latimes - 🏆 11. / 82 Read more »

NPR Cookie Consent and ChoicesWho has final say of CDCgov acip contradicts this? BoosterShots
Source: NPRHealth - 🏆 144. / 63 Read more »

Covid-19 vaccine boosters can begin for some US adults as CDC partially diverges from its advisers' recommendationsFollowing days of lengthy debate among vaccine experts, booster shots of the Pfizer/BioNTech Covid-19 vaccine can now be officially administered to some adults in the United States. Blah blah blah My arm is ready
Source: cnnbrk - 🏆 393. / 55 Read more »

Im afraid i may unknowingly have Covid at the time of vaccination and have ill effects..Do they even test people for Covid first before injecting one with the vaccine? lol...
Source: USATODAY - 🏆 100. / 63 Read more »